Summit Therapeutics
SMMT
SMMT
93 hedge funds and large institutions have $60.4M invested in Summit Therapeutics in 2023 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 34 increasing their positions, 22 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
31% less capital invested
Capital invested by funds: $87.7M → $60.4M (-$27.3M)
47% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 15
Holders
93
Holding in Top 10
–
Calls
$2.1M
Puts
$165K
Top Buyers
| 1 | +$1.18M | |
| 2 | +$519K | |
| 3 | +$400K | |
| 4 |
Barclays
London,
United Kingdom
|
+$187K |
| 5 |
JPMorgan Chase & Co
New York
|
+$182K |
Top Sellers
| 1 | -$5.92M | |
| 2 | -$473K | |
| 3 | -$343K | |
| 4 |
Goldman Sachs
New York
|
-$297K |
| 5 |
Millennium Management
New York
|
-$293K |